Novel therapy for Crohn’s disease targeting IL-6 signalling

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.8, Iss.4, 2004-08, pp. : 287-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy of Crohn’s disease in childhood

By Beattie R Mark Bremner A Ronald F

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 809-825

Informa Healthcare

Access to resources Recommend Favorite

New insights into the biological therapy of Crohn’s disease

By Hassan Cesare Zullo Angelo Campo Salvatore MA Morini Sergio

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 409-419

Informa Healthcare

Access to resources Recommend Favorite

A review of standard and novel therapies in Crohn’s disease

By Rulyak S.J. Lichtenstein G.R.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. : 1021-1033

Informa Healthcare

Access to resources Recommend Favorite

IL-6 and Crohn's Disease

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 125-130

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-IL-12/23 in Crohn's Disease: Bench and Bedside

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1379-1384

Bentham Science Publishers

Access to resources Recommend Favorite